Упрощенная HTML-версия
136
108.
Cardiovascular toxicity caused by cancer treatment: strategies for early de-
tection / R. Altena [et al.] // Lancet Oncol. – 2009. – Vol. 10, № 4. – P.
391-399.
109.
Casey P. J. Protein lipidation in cell signaling / P. J. Casey // Science. –
1995. – Vol. 268, № 5208. – P. 221-225.
110.
Conklin K.A. Molecular replacement in cancer therapy: reversing cancer
metabolic and mitochondrial dysfunction, fatigue and the adverse effect of
cancer therapy / K.A. Conklin, G.L. Nicolson // Current Cancer Therapy
Reviews.-2008.-Vol. 4,№ 1.
111.
cTnT can be a useful marker for early detection of annthracycline cardio-
toxicity / S. Kilickap [et al.] // Ann Oncol–2005. – Vol. 16, № 5. – P. 798-
804.
112.
Current Concept of Anthracycline Cardiotoxicity: Pathogenesis, Diagnosis
and Prevention / В. Pfeffer [et al.] // Br. J. Cardiol. – 2009. – Vol. 16, № 2.
– Р. 85-89.
113.
Davis M. B. How to stay heart healthy in 2011: considerations for the pri-
mary prevention of cardiovascular disease in woman / M. B. Davis, C. S.
Duvernoy // Womens Health. – 2011. – Vol. 7, № 4. – P. 433-451.
114.
Dempsey К. S. Chemotherapy-Induced Cardiotoxicity in Women / K. S.
Dempsey // Crit. Care Nurs. Clin. North Am. – 2009. – Vol. 20, № 3. – Р.
343-350.
115.
Diverse effects of statins on angiogenesis: new therapeutic avenues / H. F.
Elewa [et al.] // Pharmacotherapy. – 2010. – Vol. 30, № 2. – P. 169-176.
116.
Doughan A. K. Molecular mechanisms of angiotensin II-mediated mito-
chondrial dysfunction / A. K. Doughan, D. G. Harrison, S. I. Dikalov //
Circ. Res. – 2008. – Vol. 102, № 4. – P. 488-496.
117.
Douglas D. Statins may reduce thromboembolism risk in cancer patients /
D. Douglas // Am. J. Med. – 2010. – Vol. 123. – P. 60-65.